Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin.

In this article, the effect of mesoporous silica (MS) on the physical stability and molecular dynamics of the amorphous form of Celecoxib (CEL) is investigated. It has been proven that the recrystallization process of CEL slows down with increasing the MS content. Beside the elongation of stabilization time with the increase silica content leads to an increase in the amorphous drug fraction remaining after the finished crystallization. The conducted analyses show that the observed inhibition of CEL's recrystallization is associated with the formation of a monomolecular drug layer on the silica's surface. The performed non-isothermal dielectric studies of CEL + MS systems having both fully and partially amorphous CEL shows that the biggest impact of the drug's the temperature dependences of structural relaxation time τα(T) has a crystalline fraction of the API. Silica, even in high concentration, does not modify the temperature dependence of structural relaxation of CEL. Copyright © 2022. Published by Elsevier B.V.

Citation

Daniel Kramarczyk, Justyna Knapik-Kowalczuk, Wojciech Smolka, Maria Ferreira Monteiro, Lidia Tajber, Marian Paluch. Inhibition of celecoxib crystallization by mesoporous silica - Molecular dynamics studies leading to the discovery of the stabilization origin. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2022 Apr 01;171:106132

Mesh Tags

Substances

PMID: 35077845

search → result